Company Description
B&C Biopharm(The treatment of fatty liver diseaseSafety: three phases of preclinical trials and many number of participants for clinical tests of Dr. J confirm its safety. Due to the fact that Dr. J has been developed as a pharmaceutical drug, bio-transformed Ginsenosides completed three phases of preclinical trials, which the FDA does not require for the approval of health functional food but for medicines. Clinical trials of Dr. J was practiced with 100 subjects although required numbers of participants are 40. For instance, clinical studies for the safety of genus hovenia was practiced with 40 participants.
Company Information
- Contact Person:: Ms.Linda yang (Man
- Telephone:
- Business Type:Manufacturing
- Year Established:1999
- Number Of Employees:11-15
- Trade Capacity:Export Percentage:
- Main Products:Dr. J Is Health Functional Food For Liver Health, Which Made By Platycodon Root Extract.,
- Address:South Korea
- Main Markets:Asia,America
- Website:Visit website